Margherita Sonnessa
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Predicting modelling for early diagnosis in early myeloproliferative neoplasms, not otherwise specified. Evidence from a machine learning study.
Journal: Frontiers in oncology
Published: November 07, 2025
Insight into the Regulation of NDRG1 Expression.
Journal: International journal of molecular sciences
Published: February 02, 2025
Downstream Signaling of Inflammasome Pathway Affects Patients' Outcome in the Context of Distinct Molecular Breast Cancer Subtypes.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 01, 2022
The Biological Relevance of NHERF1 Protein in Gynecological Tumors.
Journal: Frontiers in oncology
Published: December 15, 2021
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study.
Journal: Expert opinion on therapeutic targets
Published: November 30, 2021
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 16, 2021
Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients.
Journal: Frontiers in oncology
Published: May 05, 2021
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer.
Journal: Frontiers in oncology
Published: April 23, 2020
Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report.
Journal: Frontiers in oncology
Published: October 18, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026